Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol
Michael Dagher, Felicia Ruffin, Steven H. Marshall, Magdalena A. Taracila, Robert A. Bonomo, Rachel M. Reilly, Vance G. Fowler, Joshua T. Thaden
Abstract
Abstract Cefiderocol is a novel catechol siderophore cephalosporin antibiotic developed to treat resistant gram-negative infections. We describe its successful use as rescue therapy, combined with surgical debridement, to treat a patient with osteomyelitis due to extensively drug-resistant Acinetobacter baumannii. Bacterial whole-genome sequencing identified the strain and antibiotic resistance determinants.
Topics & Concepts
Acinetobacter baumanniiMedicineCephalosporinOsteomyelitisAcinetobacterDrug resistanceAntibioticsMicrobiologyPseudomonas aeruginosaIntensive care medicineBiologySurgeryBacteriaGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyBacterial Identification and Susceptibility Testing